Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a report released on Saturday. The brokerage issued a buy rating on the stock. Trinity Biotech Stock Up 1.9 % Shares of Trinity Biotech stock opened at $0.77 on Friday. Trinity Biotech has a 12-month low of $0.63 and a 12-month high […]
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research report report published on Saturday morning. The firm issued a buy rating on the stock. Trinity Biotech Price Performance Shares of NASDAQ:TRIB opened at $0.77 on Friday. The firm’s 50 day simple moving average is $0.95 and its 200 day […]
The Premier Resolution System quantifies hemoglobins F and A2 and detects more than 200 hemoglobin variants.
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.
DUBLIN--(BUSINESS WIRE)--Aug 3, 2023--